Brini, Stefano http://orcid.org/0000-0002-1909-1796
Sohrabi, Hamid R.
Hebert, Jeffrey J.
Forrest, Mitchell R. L.
Laine, Matti
Hämäläinen, Heikki
Karrasch, Mira
Peiffer, Jeremiah J.
Martins, Ralph N.
Fairchild, Timothy J.
Funding for this research was provided by:
Murdoch University (NA)
Academy of Finland (260276, 323251)
Article History
Received: 21 January 2019
Accepted: 3 January 2020
First Online: 8 February 2020
Change Date: 13 March 2020
Change Type: Correction
Change Details: The original version of this article unfortunately contained the following mistakes.
Compliance with Ethical Standards
:
: SB received a scholarship from Murdoch University. ML was supported by the Academy of Finland (grants #260276 and #323251) and the Åbo Akademi University Endowment (the BrainTrain project). RNM is the co-Founder of the KaRa Institute of Neurological Diseases and has stocks on Alzhyme Ltd. HRS has received/is receiving remunerations from Australian Alzheimer’s Research Foundation for working on several clinical trials associated with Takeda, Merck, AstraZeneca, and Eli Lilly.
: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adap- tation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, pro- vide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.